<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00204022</url>
  </required_header>
  <id_info>
    <org_study_id>EWPSLE-LN-02</org_study_id>
    <nct_id>NCT00204022</nct_id>
  </id_info>
  <brief_title>Mycophenolate Mofetil Versus Azathioprine for Maintenance Therapy of Lupus Nephritis.</brief_title>
  <acronym>MAINTAIN</acronym>
  <official_title>A Randomized Multicenter Trial Comparing Mycophenolate Mofetil and Azathioprine as Remission-maintaining Treatment for Proliferative Lupus Glomerulonephritis. The MAINTAIN Nephritis Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Frédéric A. Houssiau, MD, PhD</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Université Catholique de Louvain</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to determine whether mycophenolate mofetil is superior to
      azathioprine to prevent flares of lupus nephritis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Proliferative glomerulonephritis is a common and severe manifestation of systemic lupus
      erythematosus (SLE) that usually requires intensive therapy with high doses of
      glucocorticosteroids and cytotoxic drugs, such as intravenous (IV) cyclophosphamide (CYC).
      The objective of the MAINTAIN Nephritis Trial is to compare mycophenolate mofetil (MMF) and
      azathioprine (AZA), in terms of efficacy and toxicity, as remission-maintaining treatment of
      proliferative lupus glomerulonephritis, after a remission-inducing therapy with a
      short-course IV CYC regimen. The hypothesis addressed by the MAINTAIN Nephritis Trial is that
      MMF is superior to AZA.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2001</start_date>
  <completion_date type="Actual">August 2011</completion_date>
  <primary_completion_date type="Actual">August 2011</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Time to renal flare</measure>
    <time_frame>5 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of withdrawals due to toxicity</measure>
    <time_frame>5 years and 10 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cumulated glucocorticoid intake</measure>
    <time_frame>5 years and 10 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of treatment failures</measure>
    <time_frame>5 years and 10 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>24-hour proteinuria over time</measure>
    <time_frame>5 years and 10 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum creatinine titers</measure>
    <time_frame>5 years and 10 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to renal flare</measure>
    <time_frame>10 years</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">105</enrollment>
  <condition>Lupus Nephritis</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Mycophenolate mofetil (target dose 2g/day)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Azathioprine (target dose 2mg/kg/day)</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Mycophenolate mofetil</intervention_name>
    <description>Mycophenolate mofetil</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Azathioprine</intervention_name>
    <description>Azathioprine</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  SLE aged ≥ 14 years

          -  Proteinuria ≥ 500 mg/day

          -  Biopsy-proven proliferative lupus nephritis

        Exclusion Criteria:

          -  Recent treatment with high-dose glucocorticoids

          -  Recent treatment with immunosuppressive drugs

          -  More exclusion criteria in the protocol
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>14 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Frédéric A Houssiau, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Université Catholique de Louvain</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Université catholique de Louvain</name>
      <address>
        <city>Bruxelles</city>
        <zip>B-1200</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>October 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 12, 2005</study_first_submitted>
  <study_first_submitted_qc>September 12, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 20, 2005</study_first_posted>
  <last_update_submitted>October 13, 2011</last_update_submitted>
  <last_update_submitted_qc>October 13, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 14, 2011</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Université Catholique de Louvain</investigator_affiliation>
    <investigator_full_name>Frédéric A. Houssiau, MD, PhD</investigator_full_name>
    <investigator_title>Professeur Ordinaire, Chef de Service Clinique</investigator_title>
  </responsible_party>
  <keyword>Lupus nephritis</keyword>
  <keyword>Treatment</keyword>
  <keyword>Maintenance therapy</keyword>
  <keyword>Mycophenolate mofetil</keyword>
  <keyword>Azathioprine</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nephritis</mesh_term>
    <mesh_term>Lupus Nephritis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Mycophenolic Acid</mesh_term>
    <mesh_term>Azathioprine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

